Jean Co.,Ltd (TPE:2442)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,964	6,598	6,330	3,356	3,327	2,761
Market Cap Growth	-5.45%	4.23%	88.61%	0.88%	20.52%	-6.08%
Enterprise Value	22,775	15,241	12,523	9,507	9,202	9,657
Last Close Price	26.60	25.20	24.08	12.73	12.24	10.06
PE Ratio	32.03	20.95	14.87	23.83	6.93	17.95
PS Ratio	5.77	6.03	2.53	6.13	2.18	0.52
PB Ratio	1.27	1.22	1.25	0.75	0.76	0.70
P/TBV Ratio	1.47	1.41	1.46	0.87	0.89	0.83
P/FCF Ratio	-	-	9.48	-	120.52	-
P/OCF Ratio	-	-	9.43	-	108.60	-
EV/Sales Ratio	18.87	13.93	5.00	17.36	6.02	1.82
EV/EBITDA Ratio	94.55	65.79	35.45	-	27.13	60.96
EV/EBIT Ratio	110.68	67.05	36.18	-	27.47	198.44
EV/FCF Ratio	-3.92	-	18.75	-	333.34	-
Debt / Equity Ratio	3.04	2.95	1.42	1.51	1.47	1.61
Debt / EBITDA Ratio	69.39	60.85	18.72	262.33	17.44	22.66
Debt / FCF Ratio	-	-	10.81	-	233.90	-
Asset Turnover	0.06	0.05	0.16	0.04	0.13	0.42
Inventory Turnover	0.06	0.05	0.19	0.05	0.13	0.61
Quick Ratio	0.10	0.10	0.23	0.12	0.17	0.27
Current Ratio	1.33	1.34	1.37	1.35	1.53	1.60
Return on Equity (ROE)	4.07%	6.00%	8.92%	3.11%	11.46%	2.83%
Return on Assets (ROA)	0.59%	0.67%	1.37%	-0.04%	1.77%	0.24%
Return on Capital (ROIC)	0.73%	0.84%	1.83%	-0.05%	1.98%	0.27%
Return on Capital Employed (ROCE)	2.40%	2.70%	5.50%	-	6.50%	0.90%
Earnings Yield	3.14%	4.77%	6.72%	4.20%	14.43%	5.57%
FCF Yield	-83.50%	-81.17%	10.55%	-24.65%	0.83%	-33.42%
Dividend Yield	0.29%	0.32%	0.45%	0.38%	1.50%	0.90%
Payout Ratio	13.25%	8.95%	2.98%	34.74%	5.00%	7.38%
Buyback Yield / Dilution	0.22%	0.13%	0.08%	1.55%	5.89%	-7.40%
Total Shareholder Return	0.52%	0.45%	0.53%	1.93%	7.39%	-6.50%

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.